• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by LumiraDx Inc

    LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Reports Second Quarter 2023 Results
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Reports First Quarter 2023 Results
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Announces Strategic Refocus and Cost Restructuring Program
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Reports Fourth Quarter and Full Year 2022 Results
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx to Present at Raymond James Institutional Investors Conference
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Regains Compliance with Nasdaq Continued Listing Requirements
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UK
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing Centers
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx Reports Third Quarter 2022 Results
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9
    From LumiraDx Inc
    Via GlobeNewswire
    Tickers LMDX
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.